| Announce Date | 11/07/2025 |
| EPS Normalized Actual | $-0.32 (Miss by $-0.04) |
| EPS GAAP Actual | $-0.32 (Miss by $-0.04) |
| Revenue Actual | $0.001225B |
| Revenue Surprise | Beat by $1.225M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.42 |
| EPS GAAP Estimate | $-0.42 |
| Revenue Estimate | $0.000135749B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -0.6875 | -5.22 | -1.22515 | 0.12013 | 2 |
| Dec 2028 | -1.35 | -2.66 | -1.35 | -1.35 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.32 | 0.08 | 0.001225B | 82.94% | 0.98M |
| FQ2 2025 (Jun 2025) | -0.41 | 0.02 | 0.001115B | -3287.8% | 1.12M |
| FQ1 2025 (Mar 2025) | -0.4 | 0.04 | 0.001454B | 59.35% | 1.45M |
| FQ4 2024 (Dec 2024) | -0.35 | 0.07 | 0.002183B | 100% | -0.85M |
| FQ1 2021 (Mar 2021) | -12.15 | -12.15 | 0B | NAN% | 0M |
| FQ2 2021 (Jun 2021) | -0.0441 | -0.0441 | 0.009132B | 100% | 9.13M |
| FQ3 2024 (Sep 2024) | -0.44 | -0.033 | 0.000209B | 100% | -2.71M |
| FQ2 2024 (Jun 2024) | -0.46 | -1.79835 | 0.037774B | 100% | 37.77M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.42
Consensus Revenue Estimates
0.000135749B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.45 | -- | -0.45 | -0.45 | 1 |
| FQ3 2026 (Sep 2026) | -0.44 | 27.27 | -0.44 | -0.44 | 1 |
| FQ2 2026 (Jun 2026) | -0.43 | 4.65 | -0.43 | -0.43 | 1 |
| FQ1 2026 (Mar 2026) | -0.42 | 4.76 | -0.42 | -0.42 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 3 |
| FQ3 2026 (Sep 2026) | 0B | -942 | 0B | 0B | 3 |
| FQ2 2026 (Jun 2026) | 0B | -782.62 | 0B | 0B | 3 |
| FQ1 2026 (Mar 2026) | 0B | -971.09 | 0B | 0B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.4 | -0.32 | 0.08 | -25% |
| FQ2 2025 (Jun 2025) | -0.43 | -0.41 | 0.02 | -4.88% |
| FQ1 2025 (Mar 2025) | -0.44 | -0.4 | 0.04 | -10% |
| FQ4 2024 (Dec 2024) | -0.42 | -0.35 | 0.07 | -20% |
| FQ1 2021 (Mar 2021) | -12.15 | -12.15 | 100% | |
| FQ2 2021 (Jun 2021) | -0.0441 | -0.0441 | 100% | |
| FQ3 2024 (Sep 2024) | -0.407 | -0.44 | -0.033 | 7.5% |
| FQ2 2024 (Jun 2024) | 1.33835 | -0.46 | -1.79835 | 390.95% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0.98M | 79.72% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $1.12M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $1.45M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-0.85M | -38.95% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
| FQ2 2021 (Jun 2021) | $0B | $0.01B | $9.13M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $-2.71M | -1298.19% |
| FQ2 2024 (Jun 2024) | $0B | $0.04B | $37.77M | 100% |